# Exploring the efficacy of new potential bio-insecticides produced by Penicillium oxalicum against Culex pipiens larvae

**Authors:** Hayam A. E. Sayed, Enas H. S. Ghallab, Ahmed M. Elissawy, Peter F. Farag, Nevin A. Ibrahim

PMC · DOI: 10.1186/s12866-026-04783-5 · BMC Microbiology · 2026-02-25

## TL;DR

A new fungal strain produces bio-insecticides that effectively kill mosquito larvae, offering a green alternative to synthetic insecticides.

## Contribution

Identification of physcion and deoxybrevianamide E as novel larvicidal compounds from Penicillium oxalicum with potential for sustainable pest control.

## Key findings

- The fungal extract achieved up to 99.98% larval mortality under optimized conditions.
- Deoxybrevianamide E showed higher potency with an LC50 of 0.84 µg/mL compared to physcion.
- Molecular docking revealed interactions with insect receptors, suggesting mechanisms of action.

## Abstract

Synthetic insecticides are major contributors to environmental pollution and the emergence of resistance. Fungal-derived metabolites are known to be environmentally friendly, selective alternatives. Thus, in the context of a green environment, this study aimed to evaluate the larvicidal activity of a mangrove-associated endophytic Penicillium oxalicum (OQ231606.1) against Culex pipiens using a larval mortality bioassay and molecular docking.

The culture filtrate extract of the examined P. oxalicum OQ231606.1 strain caused up to 80% mortality (optimized to 99.98%). Metabolite production conditions were optimized using a full factorial design followed by a central composite design. Optimum conditions were pH 6, 1.2 × 106 spores/mL inoculum, 28 °C, for 20 days. Physcion and deoxybrevianamide E, two bioactive compounds with newly reported biolarvicidal activity, were isolated from the fungal extract and structurally elucidated via NMR spectroscopy. C. pipiens third-instar larvae treated with various concentrations of these compounds showed increased mortality with increasing concentrations. Notably, deoxybrevianamide E was more potent, with an LC₅₀ value less than 1 µg/mL at 48 h (LC50 = 0.84 µg/mL vs. Physcion’s = 12.64 µg/mL). Docking analysis revealed potential insect receptors interacting with candidate compounds, showing deoxybrevianamide E and okaramine B (control) share the same active site, targeting glutamate-gated chloride channel (GluCl) with binding affinities of − 9.5 Kcal/mol and − 9.1 Kcal/mol, respectively. Whereas physcion and emodin (control) target acetylcholinesterase (AChE), with binding affinities of − 8.5 Kcal/mol and − 8.9 Kcal/mol, respectively.

This study highlights P. oxalicum OQ231606.1 as a sustainable reservoir for bioinsecticide development, identifying physcion and deoxybrevanamide E as bioactive compounds with newly reported biolarvicidal activity that represent promising candidates for green vector control strategies.

The online version contains supplementary material available at 10.1186/s12866-026-04783-5.

## Linked entities

- **Chemicals:** physcion (PubChem CID 10639), deoxybrevianamide E (PubChem CID 182203), okaramine B (PubChem CID 14312904), emodin (PubChem CID 3220)
- **Species:** Penicillium oxalicum (taxon 69781), Culex pipiens (taxon 7175)

## Full-text entities

- **Species:** Penicillium oxalicum (species) [taxon 69781], Culex pipiens (common house mosquito, species) [taxon 7175]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13041276/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13041276/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC13041276/full.md

---
Source: https://tomesphere.com/paper/PMC13041276